Yards advises NextStage AM on its €16M investment in the Médiprix gro

The law firm Yards has advised NextStage AM on its €16 million investment in the Médiprix group, a leading player in the field of support and intelligent healthcare for pharmacies. This investment is being made through the Pépites & Territoires by AXA & NextStage AM programme, which has been awarded the Relance label.

Founded in 2016 in Montpellier by Bertrand Pagès and Jérôme Escojido, Médiprix is one of the most innovative players in terms of support and intelligent health for pharmacies.

The company’s aim is to innovate in the service of people by developing new digital tools and services. The group now has a network of more than 220 pharmacies throughout France, employing nearly 2,200 healthcare professionals. Médiprix has enjoyed strong growth since 2019, with sales reaching more than €850m. This is due to its differentiating, virtuous and accessible offering and model, which respect strong social and environmental commitments.

This transaction will enable the Médiprix group to accelerate the development of its network and offer new digital e-health solutions for pharmacies, healthcare professionals and patients. The company aims to position itself as one of the leading healthcare platforms in France and Europe.

The Yards team comprised Igor Doumenc, Julien Brouwer and Laurie Martel on the M&A aspects, Dorothée Traverse and Marin du Repaire on the tax aspects and Christine Hillig-Poudevigne and Marie Yobo on the social aspects.